Conformationally constrained, fully synthetic macrocyclic compounds
Conformationally restricted, spatially defined 12-30 membered macrocyclic ring systems of formulae Ia and Ib are constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. These macrocycles Ia and Ib are readily manufactured by parallel synthesis or combinatori...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Marx Karsten Ermert Philipp Luther Anatol Oumouch Said Möhle Kerstin Lach Franck Obrecht Daniel |
description | Conformationally restricted, spatially defined 12-30 membered macrocyclic ring systems of formulae Ia and Ib are constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. These macrocycles Ia and Ib are readily manufactured by parallel synthesis or combinatorial chemistry in solution or on solid phase. They are designed to interact with a variety of specific biological target classes, examples being the agonistic or antagonistic activity on G-protein coupled receptors (GPCRs), ion channels and signal transduction pathways. In particular, these macrocycles act as antagonists of the motilin receptor, the FP receptor and the purinergic receptors P2Y1, as modulators of the serotonin receptor of subtype 5-HT2B, as blockers of the voltage-gated potassium channel Kv1.3 and as inhibitors of the -catenin-dependent canonical Wnt pathway. Thus they are showing great potential as medicaments for a variety of diseases. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9512139B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9512139B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9512139B23</originalsourceid><addsrcrecordid>eNrjZHB2zs9Lyy_KTSzJzM9LzMmpVEjOzysuKUrMzEtN0VFIKwUJFVfmlWSklmQmK-QmJhflJ1cm5wDZyfm5BfmleSnFPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7UkPjTY0tTQyNDY0snImAglAK2GM2c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Conformationally constrained, fully synthetic macrocyclic compounds</title><source>esp@cenet</source><creator>Marx Karsten ; Ermert Philipp ; Luther Anatol ; Oumouch Said ; Möhle Kerstin ; Lach Franck ; Obrecht Daniel</creator><creatorcontrib>Marx Karsten ; Ermert Philipp ; Luther Anatol ; Oumouch Said ; Möhle Kerstin ; Lach Franck ; Obrecht Daniel</creatorcontrib><description>Conformationally restricted, spatially defined 12-30 membered macrocyclic ring systems of formulae Ia and Ib are constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. These macrocycles Ia and Ib are readily manufactured by parallel synthesis or combinatorial chemistry in solution or on solid phase. They are designed to interact with a variety of specific biological target classes, examples being the agonistic or antagonistic activity on G-protein coupled receptors (GPCRs), ion channels and signal transduction pathways. In particular, these macrocycles act as antagonists of the motilin receptor, the FP receptor and the purinergic receptors P2Y1, as modulators of the serotonin receptor of subtype 5-HT2B, as blockers of the voltage-gated potassium channel Kv1.3 and as inhibitors of the -catenin-dependent canonical Wnt pathway. Thus they are showing great potential as medicaments for a variety of diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161206&DB=EPODOC&CC=US&NR=9512139B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161206&DB=EPODOC&CC=US&NR=9512139B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Marx Karsten</creatorcontrib><creatorcontrib>Ermert Philipp</creatorcontrib><creatorcontrib>Luther Anatol</creatorcontrib><creatorcontrib>Oumouch Said</creatorcontrib><creatorcontrib>Möhle Kerstin</creatorcontrib><creatorcontrib>Lach Franck</creatorcontrib><creatorcontrib>Obrecht Daniel</creatorcontrib><title>Conformationally constrained, fully synthetic macrocyclic compounds</title><description>Conformationally restricted, spatially defined 12-30 membered macrocyclic ring systems of formulae Ia and Ib are constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. These macrocycles Ia and Ib are readily manufactured by parallel synthesis or combinatorial chemistry in solution or on solid phase. They are designed to interact with a variety of specific biological target classes, examples being the agonistic or antagonistic activity on G-protein coupled receptors (GPCRs), ion channels and signal transduction pathways. In particular, these macrocycles act as antagonists of the motilin receptor, the FP receptor and the purinergic receptors P2Y1, as modulators of the serotonin receptor of subtype 5-HT2B, as blockers of the voltage-gated potassium channel Kv1.3 and as inhibitors of the -catenin-dependent canonical Wnt pathway. Thus they are showing great potential as medicaments for a variety of diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB2zs9Lyy_KTSzJzM9LzMmpVEjOzysuKUrMzEtN0VFIKwUJFVfmlWSklmQmK-QmJhflJ1cm5wDZyfm5BfmleSnFPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7UkPjTY0tTQyNDY0snImAglAK2GM2c</recordid><startdate>20161206</startdate><enddate>20161206</enddate><creator>Marx Karsten</creator><creator>Ermert Philipp</creator><creator>Luther Anatol</creator><creator>Oumouch Said</creator><creator>Möhle Kerstin</creator><creator>Lach Franck</creator><creator>Obrecht Daniel</creator><scope>EVB</scope></search><sort><creationdate>20161206</creationdate><title>Conformationally constrained, fully synthetic macrocyclic compounds</title><author>Marx Karsten ; Ermert Philipp ; Luther Anatol ; Oumouch Said ; Möhle Kerstin ; Lach Franck ; Obrecht Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9512139B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Marx Karsten</creatorcontrib><creatorcontrib>Ermert Philipp</creatorcontrib><creatorcontrib>Luther Anatol</creatorcontrib><creatorcontrib>Oumouch Said</creatorcontrib><creatorcontrib>Möhle Kerstin</creatorcontrib><creatorcontrib>Lach Franck</creatorcontrib><creatorcontrib>Obrecht Daniel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Marx Karsten</au><au>Ermert Philipp</au><au>Luther Anatol</au><au>Oumouch Said</au><au>Möhle Kerstin</au><au>Lach Franck</au><au>Obrecht Daniel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Conformationally constrained, fully synthetic macrocyclic compounds</title><date>2016-12-06</date><risdate>2016</risdate><abstract>Conformationally restricted, spatially defined 12-30 membered macrocyclic ring systems of formulae Ia and Ib are constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. These macrocycles Ia and Ib are readily manufactured by parallel synthesis or combinatorial chemistry in solution or on solid phase. They are designed to interact with a variety of specific biological target classes, examples being the agonistic or antagonistic activity on G-protein coupled receptors (GPCRs), ion channels and signal transduction pathways. In particular, these macrocycles act as antagonists of the motilin receptor, the FP receptor and the purinergic receptors P2Y1, as modulators of the serotonin receptor of subtype 5-HT2B, as blockers of the voltage-gated potassium channel Kv1.3 and as inhibitors of the -catenin-dependent canonical Wnt pathway. Thus they are showing great potential as medicaments for a variety of diseases.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US9512139B2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Conformationally constrained, fully synthetic macrocyclic compounds |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A21%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Marx%20Karsten&rft.date=2016-12-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9512139B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |